vs
太平洋生物科学（ASMB）与Finward Bancorp（FNWD）财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是太平洋生物科学的1.5倍（$16.5M vs $10.8M），Finward Bancorp净利率更高（12.0% vs -85.2%，领先97.2%），太平洋生物科学同比增速更快（57.6% vs 1.1%），Finward Bancorp自由现金流更多（$9.0M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
ASMB vs FNWD — 直观对比
营收规模更大
FNWD
是对方的1.5倍
$10.8M
营收增速更快
ASMB
高出56.5%
1.1%
净利率更高
FNWD
高出97.2%
-85.2%
自由现金流更多
FNWD
多$24.2M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $16.5M |
| 净利润 | $-9.2M | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 11.0% |
| 净利率 | -85.2% | 12.0% |
| 营收同比 | 57.6% | 1.1% |
| 净利润同比 | 4.3% | -5.6% |
| 每股收益（稀释后） | $-0.72 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBFNWD
| Q4 25 | — | $16.5M | ||
| Q3 25 | $10.8M | $17.4M | ||
| Q2 25 | $9.6M | $16.6M | ||
| Q1 25 | $9.4M | $15.5M | ||
| Q4 24 | $7.4M | $16.3M | ||
| Q3 24 | $6.8M | $14.9M | ||
| Q2 24 | $8.5M | $14.6M | ||
| Q1 24 | $5.8M | $25.3M |
净利润ASMBFNWD
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-9.2M | $3.5M | ||
| Q2 25 | $-10.2M | $2.2M | ||
| Q1 25 | $-8.8M | $455.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-9.6M | $606.0K | ||
| Q2 24 | $-11.2M | $143.0K | ||
| Q1 24 | $-9.1M | $9.3M |
营业利润率ASMBFNWD
| Q4 25 | — | 11.0% | ||
| Q3 25 | -100.9% | 20.5% | ||
| Q2 25 | -115.2% | 12.7% | ||
| Q1 25 | -105.5% | 4.0% | ||
| Q4 24 | — | 16.3% | ||
| Q3 24 | -160.1% | 2.7% | ||
| Q2 24 | -143.0% | 0.9% | ||
| Q1 24 | -185.5% | 40.6% |
净利率ASMBFNWD
| Q4 25 | — | 12.0% | ||
| Q3 25 | -85.2% | 20.1% | ||
| Q2 25 | -105.9% | 12.9% | ||
| Q1 25 | -93.6% | 2.9% | ||
| Q4 24 | — | 12.9% | ||
| Q3 24 | -140.4% | 4.1% | ||
| Q2 24 | -130.7% | 1.0% | ||
| Q1 24 | -156.9% | 36.7% |
每股收益（稀释后）ASMBFNWD
| Q4 25 | — | $0.46 | ||
| Q3 25 | $-0.72 | $0.81 | ||
| Q2 25 | $-1.33 | $0.50 | ||
| Q1 25 | $-1.17 | $0.11 | ||
| Q4 24 | — | $0.50 | ||
| Q3 24 | $-1.51 | $0.14 | ||
| Q2 24 | $-1.98 | $0.03 | ||
| Q1 24 | $-1.66 | $2.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $174.7M |
| 总资产 | $240.0M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBFNWD
| Q4 25 | — | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $18.7M | — |
股东权益ASMBFNWD
| Q4 25 | — | $174.7M | ||
| Q3 25 | $182.7M | $165.5M | ||
| Q2 25 | $18.1M | $154.3M | ||
| Q1 25 | $27.1M | $151.8M | ||
| Q4 24 | $33.4M | $151.4M | ||
| Q3 24 | $26.0M | $159.6M | ||
| Q2 24 | $34.7M | $148.6M | ||
| Q1 24 | $32.6M | $151.6M |
总资产ASMBFNWD
| Q4 25 | — | $2.0B | ||
| Q3 25 | $240.0M | $2.1B | ||
| Q2 25 | $80.8M | $2.1B | ||
| Q1 25 | $99.0M | $2.0B | ||
| Q4 24 | $119.2M | $2.1B | ||
| Q3 24 | $100.3M | $2.1B | ||
| Q2 24 | $115.3M | $2.1B | ||
| Q1 24 | $119.9M | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $9.0M |
| 自由现金流率自由现金流/营收 | -140.7% | 54.8% |
| 资本支出强度资本支出/营收 | 0.4% | 5.2% |
| 现金转化率经营现金流/净利润 | — | 4.99× |
| 过去12个月自由现金流最近4个季度 | — | $10.6M |
8季度趋势，按日历期对齐
经营现金流ASMBFNWD
| Q4 25 | — | $9.9M | ||
| Q3 25 | $-15.1M | $1.2M | ||
| Q2 25 | $-16.8M | $4.8M | ||
| Q1 25 | $-23.4M | $-3.8M | ||
| Q4 24 | $-51.1M | $9.8M | ||
| Q3 24 | $-15.2M | $-3.7M | ||
| Q2 24 | $-17.1M | $2.8M | ||
| Q1 24 | $-18.4M | $-25.0K |
自由现金流ASMBFNWD
| Q4 25 | — | $9.0M | ||
| Q3 25 | $-15.2M | $1.0M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | $-51.1M | $6.7M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | $-17.1M | $1.1M | ||
| Q1 24 | $-18.4M | $-736.0K |
自由现金流率ASMBFNWD
| Q4 25 | — | 54.8% | ||
| Q3 25 | -140.7% | 6.0% | ||
| Q2 25 | — | 27.0% | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | -695.2% | 41.2% | ||
| Q3 24 | — | -28.5% | ||
| Q2 24 | -200.6% | 7.6% | ||
| Q1 24 | -317.7% | -2.9% |
资本支出强度ASMBFNWD
| Q4 25 | — | 5.2% | ||
| Q3 25 | 0.4% | 0.9% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.4% | 18.8% | ||
| Q3 24 | 0.0% | 3.4% | ||
| Q2 24 | 0.2% | 11.2% | ||
| Q1 24 | 0.2% | 2.8% |
现金转化率ASMBFNWD
| Q4 25 | — | 4.99× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | -8.37× | ||
| Q4 24 | — | 4.66× | ||
| Q3 24 | — | -6.15× | ||
| Q2 24 | — | 19.23× | ||
| Q1 24 | — | -0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
